- Merck & Co. (Rahway, NJ)
- Job DescriptionThe Analytical Research & Development, Cell Based Sciences in Rahway, NJ is seeking a motivated senior level scientist with extensive experience in ... interacting with Health Authorities.Education, Qualifications, and Skills: Ph.D. in cell biology, immunology, biochemistry, molecular biology, or related field with… more
- Merck & Co. (Rahway, NJ)
- Job Description Join Our Team as a Biologics Cell Culture Leader! The primary objective of the Biologics Drug Substance Commercialization (BDSC), Cell Culture ... seeking a strategic and technical leader with expertise in cell culture development & commercialization to spearhead our ever...Why You'll Love This Role: - As a Biologics Cell Culture Commercialization Leader, you'll be at the forefront… more
- BioAgilytix (Durham, NC)
- …home here at BioAgilytix.Essential ResponsibilitiesPrepare worksheets with minimal supervisionRun cell -based assays independently Examples of assays may include Flow ... Cytometry, ELISA, qPCR, ddPCR, USP CompendialsPrepare plate mapsServe as lead analyst on sample analysis projectsTroubleshoot assaysCompile/process data (make power export)Prepare summary tablesPeer review raw dataOrder reagentsParticipate in assay development… more
- Insmed Incorporated (NJ)
- …several pre-clinical projects. This will involve assisting with tasks such as cell culture, in vitro hematopoietic stem cell expansion and differentiation, ... western blot, and ELISA.What You'll Do: Culture primary cells and continuous cell lines such as neutrophils, hematopoietic stem cells, immune cells, and/or relevant… more
- Merck & Co. (Rahway, NJ)
- …interacting with other teams within BPD and staff in Process Cell Science, US Operations, Clinical Manufacturing, and Commercial Manufacturing groups. The ... team environment. The candidate is expected to be experienced in mammalian cell culture or purification process development, tech transfer of clinical or/and… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Insmed Incorporated (NJ)
- …support downstream analyses from in vivo studies.What You'll Do: Lead cell -based assay development, perform efficacy assessment across primary and follow-up compound ... and maintain common lines (eg, Jurkat, THP-1, HL-60, RAW264.7) and other relevant cell lines for in vitro / ex vivo assays.Plan and execute experiments using… more
- Legend Biotech USA, Inc. (Philadelphia, PA)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer (NK) cell -based immunotherapy. From our three R&D sites around… more
